AnaptysBio, Inc. (ANAB)

56.49 +1.08 (+1.95%) USD  |  NASDAQ  |  Feb 25, 13:03
More

AnaptysBio Accrued Expenses (Quarterly)

Accrued Expenses (Quarterly) Chart

View Accrued Expenses (Quarterly) for ANAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Accrued Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Accrued Expenses (Quarterly) Range, Past 5 Years

View Accrued Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Accrued Expenses (Quarterly) Benchmarks

View Accrued Expenses (Quarterly) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. --
Nektar Therapeutics Upgrade
Rigel Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade